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Background: Low birth weight and maternal anemia remain intractable problems in many developing countries.
The adequacy of the current strategy of providing iron-folic acid (IFA) supplements only during pregnancy has
been questioned given many women enter pregnancy with poor iron stores, the substantial micronutrient demand
by maternal and fetal tissues, and programmatic issues related to timing and coverage of prenatal care. Weekly IFA
supplementation for women of reproductive age (WRA) improves iron status and reduces the burden of anemia in
the short term, but few studies have evaluated subsequent pregnancy and birth outcomes.
The Preconcept trial aims to determine whether pre-pregnancy weekly IFA or multiple micronutrient (MM)
supplementation will improve birth outcomes and maternal and infant iron status compared to the current practice
of prenatal IFA supplementation only. This paper provides an overview of study design, methodology and sample
characteristics from baseline survey data and key lessons learned.
Methods/design: We have recruited 5011 WRA in a double-blind stratified randomized controlled trial in rural
Vietnam and randomly assigned them to receive weekly supplements containing either: 1) 2800 μg folic acid 2) 60
mg iron and 2800 μg folic acid or 3) MM. Women who become pregnant receive daily IFA, and are being followed
through pregnancy, delivery, and up to three months post-partum. Study outcomes include birth outcomes and
maternal and infant iron status. Data are being collected on household characteristics, maternal diet and mental
health, anthropometry, infant feeding practices, morbidity and compliance.
Discussion: The study is timely and responds to the WHO Global Expert Consultation which identified the need to
evaluate the long term benefits of weekly IFA and MM supplementation in WRA. Findings will generate new
information to help guide policy and programs designed to reduce the burden of anemia in women and children
and improve maternal and child health outcomes in resource poor settings.
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Low birth weight (LBW) (birth weight < 2500 g) and
anemia remain intractable problems in many developing
countries [1-3]. Little progress has been made in redu-
cing the prevalence of LBW despite several decades of
program implementation that includes routine daily sup-
plementation of pregnant women with iron folic acid
(IFA) through the primary health care system [4,5]. Rea-
sons for low effectiveness include inadequacy of delivery
systems, side effects and poor compliance among preg-
nant women [6]. In many parts of South and South East
Asia where LBW is high, ~30% of non-pregnant women
and 60% of pregnant women are anemic [3], primarily
due to iron deficiency, which has been associated with
poor birth outcomes [5,7-11]. Intervening with IFA sup-
plements only during pregnancy however may not be
the best approach given the substantial demands for iron
by maternal and fetal tissues [12] and the fact that many
women in these settings enter pregnancy with subopti-
mal stores [13]. Weekly IFA supplementation before
pregnancy has been considered as an alternative ap-
proach to reduce the burden of anemia and improve
birth outcomes [14,15]. Weekly IFA supplementation
has been shown to improve iron status and reduce the
burden of anemia in women of reproductive age (WRA)
in the short term, but very few studies have evaluated
subsequent pregnancy outcomes. Pre-pregnancy weekly
IFA supplementation has been shown to improve iron
status and reduce anemia during pregnancy compared to
prenatal daily IFA alone in three effectiveness studies
[16] conducted in Vietnam [17], Cambodia [18] and the
Philippines [19,20]. However no study has assessed the
effects of pre-pregnancy IFA supplementation on birth
outcomes.
Daily prenatal multiple micronutrient (MM) interven-
tions have also shown promising results. A recent meta-
analysis of several intervention trials that compared daily
MM to IFA supplementation estimated an overall in-
crease of 60 g in mean birth weight [21]. Other studies
reported a reduction of 14% in the incidence of low birth
weight [22] and reductions in fetal loss and infant mor-
tality [23]. Providing iron and/or MM pre-conceptually
may have even larger effects as they help meet the
increased demand for iron and other micronutrients
earlier in pregnancy. Results from a recent systematic
review suggest pre-conception and peri-conception
intake of MM supplements is associated with a
reduced risk of preterm birth, LBW and intrauterine
growth retardation [24].
Although it is highly plausible that interventions such
as weekly IFA or MM supplementation in non-pregnant
women may have long term benefits such as improved
birth outcomes as well as infant and child growth and
development, there is very little empirical evidence fromwell-designed controlled trials to inform global guide-
lines or country policy. This double blind stratified ran-
domized controlled trial in Vietnam examines whether
pre-pregnancy weekly IFA or MM supplementation
improves birth outcomes as well as maternal and infant
iron status compared to the current practice of provid-
ing only prenatal IFA supplements. This study is a col-
laborative effort between Emory University, the
Micronutrient Initiative, the Mathile Institute for the
Advancement of Human Nutrition, and the Thai Nguyen
University of Medicine and Pharmacy (TUMP) in
Vietnam. This paper will provide an overview of the
study design, methodology and sample characteristics
from our baseline survey data and note key lessons
learned from field experiences during the first year of
implementation.
Methods/design
Study design and intervention
PRECONCEPT is a stratified double-blind randomized
controlled trial in which eligible women were recruited
and randomly assigned to one of three pre-pregnancy
groups for weekly supplementation of: 1) 2800 μg folic
acid (FA – control), 2) 60 mg iron and 2800 μg folic acid
or 3) multiple micronutrients, including 60 mg iron and
2800 μg folic acid. Women who become pregnant
receive IFA to be taken daily through delivery, as recom-
mended by WHO [25]. All women are offered de-
worming at baseline and followed through delivery and
three months post-partum. Women who do not get
pregnant within 18 months of receiving the intervention
will also be followed up and evaluated for markers of
iron status.
The micronutrient composition of the supplements
provided before and during pregnancy are shown in
Table 1. Because FA is universally recommended to
WRA for the prevention of neural tube defects, provid-
ing a placebo was considered unethical. Therefore, the
control supplement includes 2800 μg FA. This dosage is
7 times the minimum recommended daily intake 400
μg/d [15] and has been shown to be safe and as effective
as a 400 μg daily dose in improving folic acid and redu-
cing homocysteine levels among WRA [26-28]. The
doses of weekly and daily IFA are based on current
WHO recommendations for WRA [15]. The compos-
ition of the MM supplement was based on the UNIM-
MAP international multiple micronutrient preparation
(UNICEF/WHO/UNU, 1999) used in daily prenatal trials
with a few modifications, namely the same amounts of
iron and folic acid as the weekly IFA supplement and a
higher amount of Vitamin D to be consistent with the
recent Institute Of Medicine recommendations [29].
The amounts of vitamins and minerals--other than
IFA--are 30-40% greater than the current recommended
Table 1 The composition of iron folic acid and multiple
micronutrient supplements




Vitamin A (μg) 800 700
Vitamin D (IU) 600 15
Vitamin E (mg) 10 15
Vitamin C (mg) 70 75
Thiamine (mg) 1.4 1.1
Riboflavin (mg) 1.4 1.1
Niacin (mg) 18 14
Vitamin B6 (mg) 1.9 1.3
Vitamin B12 (μg) 2.6 2.4
Folic acid (μg) 2800 2800 2800 400
Iron (ferrous sulfate) (mg) 60 60 18
Zinc (sulfate) (mg) 15 8
Copper 2 (mg) 900 (μg/d)
Selenium (μg) 65 55
Iodine (μg) 150 150
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the supplements are consumed only once a week and are
below the tolerable upper intake level [30].
To ensure quality, we obtained the premix for all for-
mulations from DSM Nutritional Products and had the
supplements prepared and packaged under Good Manu-
facturing Practices standard by a local pharmaceutical
factory (NewCare) that adhered to quality standards.
Samples from each production batch are sent to DSM
for quality assurance testing. To ensure adequate blind-
ing of study personnel and participants, we assigned two
color-letter schemes for each type of supplement, result-
ing in 6 unique combinations which are indicated on the
blister packages containing the supplements. All supple-
ments were in capsule form, identical in appearance and
taste, and coded with lot numbers at the factory that
correspond to one of the three treatment arms. Two
sealed envelopes containing the code allocations are
being stored by two individuals not involved in the study
at TUMP and Emory University and will be revealed
only after completion of the trial.Sample size calculations
Based on previous studies that have been done primarily
in pregnant women, we chose an effect size of 0.15 SD
as worth detecting from the point of view of public
health significance. This is equivalent to a difference of
60 g in mean birth weight (assuming a SD of 400 g);
0.27 weeks ( ~ 2 days) in mean gestational age (assum-
ing a SD of 1.8 weeks); and 2 g/dl in mean hemoglobinconcentration (assuming a SD of 1.3 g/dl) between any
two groups. Using a one tailed test of comparing means
between two groups and a significance level of α=0.05,
we estimated that we needed a minimum sample of 550
infants per group (1650 total) to have at least 80% power
to detect an effect size of 0.15 or greater [31]. Assuming
10% loss to follow-up and a pregnancy rate (among
women who plan to be pregnant) of 35%, we estimated
that we should recruit at least 5000 WRA to obtain a
sample of 1650 mother-infant pairs.
Study setting
The study is taking place in Vietnam where malnutrition
(including chronic energy and micronutrient deficien-
cies) is common in women and young children. Accord-
ing to the latest national nutrition survey, anemia is
present in 28.8% of non-pregnant, 36.5% of pregnant
women and 29.2% of children under 5 years of age [32].
The percentage of WRA with low Body Mass Index
(BMI< 18.5) was 18% and with BMI ≥ 25 was 8.2% [32].
The rate of LBW is 14% [33], the prevalence of under-
weight among children under 5 years is 17.5%, stunting
29.3% and wasting 7.1% [32]. The study is being con-
ducted in Thai Nguyen province, the gateway to
Vietnam’s mountainous northeastern region, located
about 80 kilometers northeast of Hanoi. Thai Nguyen
is home to 8 ethnic groups and 70% of its 1 million
inhabitants live in rural areas. Most residents speak
Vietnamese and work as farmers, with the main
agricultural products being tea and rice.
Study subjects were identified from 20 communes
located in 4 of Thai Nguyen’s 9 districts. Communes
were selected based on location, availability of health
services and population characteristics. The rural com-
munes each have a stable population of approximately
6000 residents of whom 1500 are WRA. A main clinic
center, or Commune Health Center (CHC), serves each
commune with average of 5 CHC staff and 10–20 village
health workers (VHW).
Subject recruitment, randomization to treatment
A list of all WRA was obtained from CHC for each com-
mune. VHW visited the homes of women on the list
who were married and not pregnant at the time to
inquire about their plans for pregnancy in the upcoming
year. Women intending to get pregnant within the next
year were invited to participate in the study. The inclu-
sion criteria were: 1) 18–35 years old, 2) currently mar-
ried, 3) living in one of the 20 communes selected with
the intention to stay in the areas for the 24 months fol-
lowing recruitment, 4) plan to have children in the next
year and 5) agree to participate with informed consent.
The rate of pregnancy before or outside marriage is very
low because of strict Vietnamese social norms. Exclusion
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sumed IFA or MM supplements in the past 2 months, 3)
severe anemia (Hemoglobin [Hb] < 7 g/L; based on test-
ing at enrollment), 4) history of high risk pregnancy and
5) reported chronic hematological diseases, hereditary
defects of red blood cells or hemoglobin. Women with
severe anemia were referred to the local health clinic for
treatment.
As participants were enrolled during baseline data col-
lection they were assigned a unique ID number. Lists of
the ID numbers organized by commune were sent to
Emory University weekly and were randomized using a
SAS generated randomization code to assign women to
one of the six supplemental groups. The randomized list
was then sent back to TUMP in Vietnam at which point
women began their supplement regimen. Group assign-
ment was double-blinded. The dosing regimen is one
capsule a week before pregnancy and seven pills a week
during pregnancy.
Pre-pregnancy supplement distribution, measurement of
compliance and detection of pregnancy
VHWs visit women every two weeks to deliver 2 cap-
sules. The VHW directly observes the consumption of
one supplement during her visit, and calls or uses text
messages the weeks in between her visits to remind the
participants to take the second supplement (cell phone
coverage is almost universal in the population). Women
are encouraged to consume supplements on an empty
stomach at the same time every week to enhance com-
pliance, absorption and minimize side-effects. During
each visit, VHWs record the number of supplements
consumed and any symptoms or side effects women
may have. Compliance is based on a count of empty cap-
sule packets stored in the women’s homes. VHWs also
ask women whether they have had their menses since
the last visit. If women report their last menstrual period
to be >5 weeks, they are invited to the CHC for a preg-
nancy test. Data on last menstrual period are recorded
to estimate gestational age. Women who test positive for
the pregnancy are scheduled for their prenatal visits at
the CHC. Upon confirmation of pregnancy, supplemen-
tation with the Preconcept capsules is discontinued and
women are given daily IFA instead.
Pregnancy supplementation, monitoring and follow-up
during pregnancy
Pregnant women receive prenatal IFA supplements and
are advised to take them daily before bed time. VHWs
continue to visit pregnant women once every two weeks
until delivery to provide supplements, monitor con-
sumption and record morbidity and side effects. All
pregnant women are scheduled for 3 prenatal visits: 1)
at 6–12 weeks, 2) at 23–28 weeks and 3) at 30–36 weeksat the CHC by trained doctors or nurses. During pre-
natal visits, doctors record obstetric history, morbidity,
workload, depression, vital signs, anthropometric mea-
surements, hemoglobin values, urinalysis results, blood
glucose and collect venous blood (for the first and sec-
ond pregnancy semesters). In addition to standard pre-
natal care, women with any serious problems are
referred to OBGYN department of Thai Nguyen General
Hospital. The TUMP study physicians are responsible
for following-up on these visits and ensuring appropriate
care is received.
Notification of birth and post-partum visit
The VHWs maintain close contact with the pregnant
women and their families, especially as the delivery date
approaches, and notify the study doctors as soon as a
birth occurs. During their third prenatal visit, women re-
ceive a delivery card with their VHW’s and study doc-
tor’s phone numbers. Women are also encouraged to
deliver in district hospitals where 90% of deliveries take
place. Women are instructed to contact the study staff
at the first sign of labor, or ask a family member to do
so. The study staff then contacts the hospitals where the
woman intends to deliver in order to alert them of the
labor and remind them to prepare for data collection at
delivery. Trained study doctors or nurses based at dis-
trict hospitals obtain the delivery data. In special cases,
when deliveries take place outside the district hospitals,
a study doctor or nurse from the CHC visits the mother
in her home or at the delivery site within 7 days after
birth to gather delivery data. Women and their new-
borns are visited at one and three month post-partum to
collect postpartum data.
Follow-up with women who do not become pregnant
Women who do not become pregnant will be removed
from the study after 18 months of supplement intake.
Upon leaving the study, these women will undergo a
health assessment and a hemoglobin test on capillary
blood using HemocueW.
Data collection
Study measurements at different time points are listed
in Table 2.
Measurement of key outcomes
Birth size: Infant anthropometry is measured as early as
possible within seven days after birth and at one and
three months postpartum using standard procedures
[34,35]. Infant anthropometry measurements include
weight, recumbent length and crown-rump length, and
the circumferences of head, mid-upper arm and abdo-
men. All measurements are obtained in duplicate by
trained district hospital staff, and a third measurement is
Table 2 Data collection and measurements
Measurements Pre-pregnancy Pregnancy Birth Post-partum
6-12 weeks 23-28 weeks 30-36 weeks
Maternal
Demographics, SES status √
OBGYN history √
Food frequency questionnaire √
Helminthic infections √
Mental health √ √ √ √ √
Morbidity √ √ √ √
Periodontitis screening √ √ √
Workload √ √ √
Blood pressure √ √ √ √
Anthropometry √ √ √ √ √
Hematological measures
Hemoglobin √ √ √ √ √
Serum ferritin √ √ √ √
Transferrin receptor √ √ √ √
Infection indicators (CRP, AGP) √ √ √ √
Other biological indicators
Vitamin A √ √ √ √
Blood Glucose √ √
Urine protein √ √ √









Infant feeding practices √
Supplement information
Supplement consumption √ √ √ √
Side effects √ √ √ √
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predetermined range.
Gestational age is calculated based on the date of last
menstrual period, a reliable method according to previ-
ous studies [36]. Ultrasounds are being provided during
routine prenatal visits to estimate gestational age and
measure fetal growth. Several indicators are being used
including gestational sac and yolk sac during first tri-
mester of pregnancy, and biparietal diameter, head cir-
cumference, abdominal circumference and femur length
during the second or third trimester of pregnancy. Inaddition, the Farr gestational assessment score is being
used at delivery [37,38].
Maternal anemia and iron status: Hb concentrations
are measured at baseline, during the three prenatal visits
and three months postpartum using HemocueW [39].
Venous blood samples (5 ml) are collected from women
by trained nurses at baseline, during the first and the
second prenatal visits and at three months post-partum.
Serum ferritin, transferrin receptor (TfR), serum C- reactive
protein (CRP) and alpha-1-acid alycoprotein (AGP) are
measured using the Sandwich ELISA technique [40].
Nguyen et al. BMC Public Health 2012, 12:898 Page 6 of 11
http://www.biomedcentral.com/1471-2458/12/898Infants’ anemia and iron status: Infant iron status is mea-
sured in cord blood samples (5 ml) obtained at delivery.
Plasma ferritin and transferrin receptor are measured by
Sandwich ELISA technique [40]. Hb concentration is
measured at three months of age from a capillary blood
sample using HemocueW [39].
Other maternal measurement
Demographic data were collected using standardized
interviewer-administered questionnaires that include
questions about demographic background, ethnicity,
marital status, education, occupation, household size
and composition.
Socioeconomic status is measured using the asset ques-
tionnaire developed by the World Bank for use in devel-
oping countries [41] and adapted for local context. The
questionnaire includes questions on home and land
ownership, housing quality (e.g., house construction
materials), access to services (water, electricity, gas, and
sanitation services), and household assets including pos-
session of various durable goods, productive assets, and
livestock.
Household food insecurity was measured using
FANTA/USAID’s Household Food Insecurity Access
Scale (HFIAS) [42]. HFIAS indicators are validated and
provide information about food insecurity at the house-
hold level with a specific focus on access-related charac-
teristics of household food insecurity. All the questions
use a 30-recall-day period.
Reproductive histories were assessed at baseline by
interviewing women about their reproductive history in-
cluding age at first menses, number of pregnancies, live
births, abortions and previous pregnancy complications.
Maternal mental health is examined at baseline, dur-
ing pregnancy and postpartum. We used the Center for
Epidemiologic Studies-Depression Scale (CES-D) [43] at
baseline and the Edinburgh Postnatal Depression Scale
(EPDS) during pregnancy and postpartum [44].
Maternal morbidity is assessed during the three pre-
natal visits and two postpartum visits with questions
related to fever, cough and cold, diarrhea, constipation
and other illness experienced during the past 30 days. In
addition, maternal periodontal diseases are assessed by a
periodontitis screening questionnaire which includes 10
questions pertaining to signs and symptoms of periodon-
tal diseases and history of periodontal treatment. Previ-
ous studies have demonstrated a relationship between
maternal periodontal disease and adverse pregnancy out-
comes, particularly preterm birth [45-47].
Dietary intake information was collected at baseline
using a semi-quantitative food frequency questionnaire
(FFQ) developed by the Vietnam National Institute of
Nutrition (NIN).Maternal anthropometric measurements are per-
formed according to standard procedures [35,48]. Mater-
nal height was measured at baseline while all other
measurements (weight, mid-upper-arm circumference,
triceps and subscapular skinfolds) are taken at baseline,
during pregnancy and postpartum. At each time
point, all measurements are taken twice. If the first
two measurements do not fall within a predetermined
range, a third measurement is taken.
Stool samples were collected at baseline. Intestinal hel-
minth infections were examined using the Kato-Katz
technique [49]. The main intestinal nematodes observed
are A. Lumbricodes, hookworm and T. Trichura. All
women recruited were given the deworming medication
Albendazole at baseline.
Maternal workload is assessed during the three pre-
natal visits by a series of questions asking women to
provide details on strenuous activities carried out the
day before, the duration of the activity and the frequency
of strenuous activity during the last 30 days.
Other information collected in the three prenatal visits
includes symptoms of preeclampsia (blood pressure,
edema, albumin in urine) and fasting blood glucose in
the first and second trimester.
Other child measurements
Infant feeding practice information is collected at one
and three months postpartum, using WHO-
recommended infant and young child feeding indicators
which are widely accepted and used to capture optimal
feeding practices in populations [50]. The core breast-
feeding indicators will be calculated based on the WHO
guidelines [50].
Child morbidity: The incidences of respiratory infec-
tion and diarrhea are assessed at one and three months
postpartum, concurrent with maternal morbidity evalua-
tions. Any child hospitalization and details of treatment
received are also recorded.
Statistical analysis
We plan to assess the impact of the interventions using
the “intention to treat” approach for the following
outcomes:
1) Maternal iron status at the beginning of pregnancy
2) Birth outcomes (infants’ birth weight, birth length
and gestational age)
3) Infant’s iron status (Hb, ferritin, TfR) at birth and Hb
at 3 months of age
4) Maternal iron status at 3 months post-partum
We will also conduct per protocol comparisons
that will take into account the compliance and dura-
tion of intervention. As a first step, the success of
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baseline characteristics across 3 experimental groups by
ANOVA test for continuous variables or Chi-square test
for categorical variables. Since the study is still blinded,
this comparison is presented in this paper by the 6 col-
ors (2 per treatment group) for key maternal and
household characteristics at the time of recruitment
(Table 3). To assess the efficacy of the trial, generalized
linear models (such as analysis of variance and regres-
sion) will be used when the dependent variable is a
continuous variable (for example, mean hemoglobin atTable 3 Selected baseline characteristics of the sample by tre
Black Brown Green
Maternal characteristics
Mean age ±SD 26.2 ± 4.4 26.0 ± 4.6 26.0 ± 4.4
Age at first married 21.8 ± 3.3 21.7 ± 3.3 21.8 ± 3.3
Minority ethnic (%) 50.2 49.5 49.5
Education level (%)
Primary school 8.5 6.5 7.4
Secondary school 55.3 56.2 57.7
High school 24.5 25.9 22.4
College or higher 11.6 11.4 12.6
Work as farmers 80.2 81.5 78.9
Obstetric history
Number of children
0 9.4 11.8 12.6
1 88.1 84.9 84.7
≥2 2.5 3.4 2.8
Last pregnancy experiences
Prenatal check up 90.6 92.3 88.9
Taking IFA or MM 75.71 80.2 77.4
C-section 13.8 14.6 15.1
LBW (<2500 g) 7.2 7.1 8.1
Premature delivery 8.0 7.9 10.4
Anthropometric measurements
Height 152.4 ±5.0 152.8 ±5.3 152.6 ±5.2
Weight 45.7 ± 5.3 45.7 ± 5.6 45.6 ± 5.5
BMI 19.6 ± 2.0 19.6 ± 2.1 19.5 ± 2.0
BMI<18.5 (%) 30.5 31.1 33.1
MUAC 24.5 ± 2.2 24.5 ± 2.3 24.5 ± 2.2
Triceps skin fold 15.8 ± 5.1 15.7 ± 5.1 15.9 ± 4.9
Subscapular skinfold 14.5 ± 5.0 14.5 ± 5.3 14.5 ± 4.8
Calf circumference 31.9 ± 2.1 31.8 ± 2.3 31.8 ± 2.2
Hematological indicators
Hemoglobin 13.0 ± 1.4 12.9 ± 1.4 12.9 ± 1.3
Anemia (%) 19.7 21.0 19.3pregnancy entry) and generalized estimating equation
will be used if the dependent variable is a binary vari-
able (for example, prevalence of anemia at pregnancy
entry). In all analyses, standard regression diagnostics
will be performed to assess model assumptions, includ-
ing examining distributions, performing any needed
transformations, and examining overall fit, residuals and
leverage. Statistical analyses will be performed with the
SAS statistical package version 9.2 [51]. All statistical
tests will be two-tailed and p values < 0.05 will be con-
sidered statistically significant.atment group
Orange Red Violet Total
26.4 ±4.7 26.0 ±4.5 26.2 ±4.7 26.2 ± 4.6
21.8 ±3.3 21.8 ±3.3 21.8 ±3.3 21.8 ± 3.3
49.2 49.0 49.6 49.5
8.6 9.1 9.4 8.2
53.1 51.6 54.3 54.7
26.8 27.6 23.2 25.1
11.5 11.7 13.1 12.0
81.6 80.8 80.6 80.6
10.9 10.5 11.9 9.4
85.0 85.8 84.9 88.1
4.1 3.7 3.1 2.5
89.2 88.6 90.6 90.0
78.2 75.6 80.8 78.0
15.5 16.5 14.5 15.0
9.9 8.6 8.7 8.3
9.7 10.7 9.3 9.3
152.4 ±5.0 152.4 ±5.2 152.4 ±5.2 152.5 ±5.2
45.4 ±5.3 45.7 ±5.9 45.5 ±5.7 45.6 ± 5.5
19.5 ±2.0 19.7 ±2.1 19.6 ±2.1 19.6 ± 2.0
30.3 31.3 31.9 31.4
24.5 ±2.2 24.6 ±2.4 24.4 ±2.3 24.5 ± 2.3
15.8 ±5.0 16.2 ±5.1 15.9 ±5.0 15.9 ± 5.0
14.3 ±5.2 14.8 ±5.3 14.5 ±5.1 14.5 ± 5.1
31.8 ±2.1 31.9 ±2.3 31.7 ±2.2 31.8 ± 2.2
12.9 ±1.4 13.0 ±1.4 13.0 ±1.3 12.9 ± 1.4
20.4 20.0 18.1 19.7
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The study design was approved by the Ethical Committee
of Institute of Social and Medicine Studies in Vietnam
and Emory University's Institutional Review Board,
Atlanta, Georgia, USA. The trial was registered in
the US Clinical Trials registry (identification number
NCT01665378). Written informed consent is obtained
from all study participants.
Results - sample characteristics at baseline
Originally, we estimated that recruiting study partici-
pants from 16 communes would provide the desired
sample size. Careful monitoring of enrollment numbers
during the first phase of recruitment (October-December
2011) made it clear that an additional 4 communes
would be needed in order to reach the target sample
size of >5,000. After a second phase of recruitment
(March –May 2012), 5011 participants had been
recruited (Figure 1). To date, after 10 months of re-
cruitment, we have had 913 pregnancies and 73 births.
The proportion of drop outs before pregnancy is
around 10% and lost to follow up during pregnancy is
low (results not shown).
Background characteristics of the study samples are
presented in Table 3. The mean age of the study subjects
was 26.2 ± 4.6 years. Nearly half the women identified
themselves as ethnic minorities. More than half com-
pleted middle school, 25.1% completed high-school, and
8.2% have less than a primary school education and
12.0% have a college education or higher. The majority
of women (80%) work as farmers and the treatment
groups do not differ in age, education, or OBGYNFigure 1 Study recruitment and randomization.history. Nearly a third of women have BMI <18.5 while
only 1.7% are categorized as overweight or obese (BMI
>25). Nearly 20% of women were anemic at baseline and
this differed by commune. There were no difference in
the baseline characteristics including measures of mater-
nal nutritional status (based on anthropometry) and
anemia by the six treatment groups, suggesting that
randomization was most likely effective in ensuring that
the treatment groups were similar.
Discussion
To our knowledge, this is one of the first RCTs that
evaluate the efficacy of providing weekly IFA or MM be-
fore pregnancy in increasing birth weight and duration
of gestation as well as maternal and infant iron status.
The study is timely in that it responds to the WHO Glo-
bal Expert Consultation, which identified the need to
evaluate the long term benefits of weekly IFA and MM
supplementation in WRA [15]. The study is being con-
ducted in a developing country setting in South East/
South Asia where anemia and iron deficiency are highly
prevalent and will provide valuable scientific evidence
that will inform policy and the formulation of appropri-
ate iron or other micronutrient recommendations for
WRA. Compared to prenatal supplements, this inter-
vention offer several promising advantages including
improved compliance, side effect reduction and
affordability.
Although this is an efficacy study, it is successfully
using the existing local health system to identify women
interested in getting pregnant and to administer a pre-
pregnancy intervention, indicating that pre-pregnancy
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levels of public health infrastructure. Much of the study’s
initial success can be attributed to the involvement of
commune leaders as well as TUMP and its affiliate hos-
pital. Commune leaders and CHC staff were approached
early on by the Co-PI in Vietnam, provided with infor-
mation about the study’s purpose and significance, and
invited to participate. Commune leaders were recruited
to assist with community mobilization, help with the re-
cruitment of village health workers and secure venues
for baseline data collection. Continued contact with
commune leaders has helped ensure sustained commu-
nity participation and helped with concerns associated
with participants’ retention.
The study has also received strong support from influ-
ential government authorities. This was accomplished by
engaging key leaders and members of health authorities
at different levels (provincial, district and commune) at
various stages of the study implementation. A unique
feature of this study is the extent to which it has been
integrated into the existing health network, especially at
the commune and village levels. Civic society and local
government at the provincial, district and commune
levels have also played an important role in providing lo-
gistical support and organization. The Vietnam Women’s
Union mobilized VHWs for supplement distributions
and encouraged women to participate in the study.
Results will be disseminated to these governmental orga-
nizations in order to provide evidence for the revision of
policies and programs designed to reduce the burden of
anemia and improve maternal and child health outcomes
in Vietnam as well as in other countries in the regions
with high burden of anemia among WRA including
Laos, Cambodia, Bangladesh, India, Nepal [3].
Another important feature of our work has been the
focus on building research capacity among medical stu-
dents and faculty at TUMP. Supervisors were recruited
from TUMP faculty and research assistants were
recruited from the student body. The local PI along with
the Co-investigators serve as important role models and
were engaged directly in providing detailed training for
all supervisors and research assistants on their specific
roles and responsibilities within the larger study objec-
tives. Refresher trainings are provided regularly and per-
sonal coaching is provided as needed. Data collection
has been standardized and supervision is rigorous and
regular. Simple guidelines and procedures for every facet
of the study was developed and tailored to the roles and
responsibilities of all study staff at all levels: TUMP
supervisors, CHC staff and VHWs. Supervision is on-
going at all levels of the study and regular meetings pro-
vide the opportunity to trouble shoot problems and
respond to issues in a timely manner. The study man-
agement board receives updates on the study’s progressmonthly, outlining study activities in each commune.
The monthly work plan (including supplement distribu-
tion, supportive supervision, prenatal and post-natal vis-
its, delivery data collection plan, etc.) is specific to each
village and organized at the commune level.
Randomization was proven to have been very success-
ful with no significant differences in baseline characteris-
tics among treatment groups. Every effort was made to
mobilize key players from all levels in order to ensure
the study produces the highest quality data possible.
Study results will be disseminated in 3 years. We expect
the findings will help generate new information to guide
policy and programs designed to reduce the burden of
anemia in women and children and to improve maternal
and child health outcomes in resource poor settings.
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